| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10908736 | Leukemia Research | 2015 | 6 Pages |
Abstract
miR signature from DLBCL biopsies can discriminate between patients with favorable and poor prognoses.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Daniel Shepshelovich, Ron Ram, Orit Uziel, Michal Kushnir, Gila Lithwick-Yanai, Moshe Hoshen, Meora Feinmesser, Osnat Bairey, Meir Lahav,